adenosine monophosphate has been researched along with Dyslipidemias in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Biondi, G; Brugaletta, G; Oliveri, R; Romano, M; Romano, R; San Lio, PM; Scicali, R; Tumminia, A | 1 |
| Li, YN; Su, Y | 1 |
| Bongardt, S; Burghoff, S; Burkart, V; Eberhard, D; Eckel, J; Flögel, U; Ikels, K; Kern, M; Klöting, N; Schrader, J; Sell, H; Tucci, S | 1 |
3 other study(ies) available for adenosine monophosphate and Dyslipidemias
| Article | Year |
|---|---|
The impact of obesity and dyslipidemia on Remdesivir effectiveness in hospitalized patients with SARS-CoV-2-related pneumonia: An observational study.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; COVID-19 Drug Treatment; Dyslipidemias; Humans; Obesity; SARS-CoV-2 | 2022 |
Remdesivir attenuates high fat diet (HFD)-induced NAFLD by regulating hepatocyte dyslipidemia and inflammation via the suppression of STING.
Topics: Adenosine Monophosphate; Administration, Oral; Alanine; Animals; Antiviral Agents; Diet, High-Fat; Dyslipidemias; Hepatocytes; Inflammation; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitates | 2020 |
Deletion of CD73 promotes dyslipidemia and intramyocellular lipid accumulation in muscle of mice.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Adipocytes; Adipose Tissue; Animals; Blood Glucose; Diet, High-Fat; Down-Regulation; Dyslipidemias; Gene Deletion; Homeostasis; Insulin; Lipid Metabolism; Lipolysis; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Skeletal; Muscles; Obesity; Phosphorylation; Proto-Oncogene Proteins c-akt | 2013 |